期刊文献+

交泰丸有效部位自微乳化释药系统的处方设计 被引量:3

Self-microemulsifying drug delivery system formulation optimization design of effective fraction of Jiaotai Pill
下载PDF
导出
摘要 目的:研究交泰丸(黄连、肉桂)有效部位自微乳化释药系统的处方工艺。方法:通过溶解度实验、乳化剂的选择、伪三元相图的绘制、处方比例的优化,以所形成自乳剂外观、乳化后乳剂的外观、自乳化时间为指标筛选最佳处方;通过药物在不同温度的溶解情况确定载药量。结果:最优处方为辛酸/葵酸甘油三酯-CremophorRH40-丙二醇-黄连总碱-肉桂油(以桂皮醛含量计)(20∶50∶30∶3∶0.6)。结论:交泰丸有效部位自微乳对药物增溶作用明显,制备方法简单。 AIM: To explore the formulation design and quality evaluation of self-microemulsifying drug delivery system (SMEDDS) from the effective constituents of Jiaotai Pill(Rhizoma Coptidis,Cortex Cinnamomi). METHODS: The self-microemulsion formulation of effective constituents of Jiaotai Pill was optimized based on its solubility in various kinds of oils,and the self-microemulsifying efficiency of various combinations of emulsifier and co-emulsifer was evaluated using the pseudo-ternary phase diagrams. The appearance,particle size in the selfemulsifying system,and the emulsifying speed were examined. RESULTS: The optimum formulations of Jiaotai Pill SMEDDS were composed of caprylic acid/capric triglyceride,Cremophor RH40,propanediol,Coptis total alkaloids,and cinnamon oil at the ratio of 20 ∶ 50 ∶ 30 ∶ 3 ∶ 0. 6,calculated as cinnamyl aldehyde. CONCLUSION: The solubility of effective fraction of Jiaotai Pill is significantly increased in self-emulsifying system and the formulation is stable and easy to prepare.
出处 《中成药》 CAS CSCD 北大核心 2010年第8期1312-1315,共4页 Chinese Traditional Patent Medicine
基金 国家自然科学基金项目(30672585)
关键词 自微乳化释药系统 处方研究 有效部位 交泰丸 self-microemulsifying drug delivery system formulation optimization design effective fraction Jiaotai Pill
  • 相关文献

参考文献6

  • 1Constantinides P P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects [J]. Pharm Res, 1995, 12 ( 11 ) : 1561-1572.
  • 2Hauss D J, Fogal S E, Ficoriljj J V,et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor [ J ]. J Pharm Sci, 1998,87 (2) : 164-169.
  • 3全世建,林杏娥,刘妮.交泰丸不同配伍比例的药效学研究[J].中药材,2006,29(2):164-166. 被引量:22
  • 4Maeng H J, Yoo H J, Kim I W, et al. P-glycoprotein-mediated transport of berberine across Caco-2 cellmonolayers [J]. J Pharm Sci, 2002, 91 (12): 2614-2621.
  • 5Yang H T, Wang G J. Transport and uptake characteristics of a new derivative of berberine (CPU-86017) by human intestinal epithelial cell line : Caco-2 [J]. Acta Pharmacol Sin, 2003,24 ( 12 ) : 1185-1191.
  • 6史朝晖,王东凯,刘莱,徐飒.α-细辛脑自微乳化释药系统的处方筛选[J].中国药剂学杂志(网络版),2005,3(3):87-91. 被引量:3

二级参考文献8

  • 1吴闯.α-细辛脑的研究进展[J].中国药学杂志,1997,32(3):129-132. 被引量:152
  • 2Imeri-L,Bianchi-S,Mancia-M.Muramyl dipeptide and IL-1 effects on sleep and brain temperature after inhibition of serotonin synthesis.Journal of Physiology,1997,273(5):2,15,47.
  • 3ArpaJ,DAnre Ⅰ.Rexamination of the effects of raphe lesion on the sleep wakefulness cyclestatesincats.J Slessp Res,1993,5(2):96-102.
  • 4Tatyana Gershanik,Sharon Benzeno,Simon Benita.Interaction of a Self-Emulsifying Lipid Drug Delivery System with the Everted Rat Intestinal Mucosa as a Function of Droplet Size and Surface Charge[J].Pharmaceutical Research.1998(6)
  • 5Panayiotis P. Constantinides.Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects[J].Pharmaceutical Research.1995(11)
  • 6Tatyana Gershanik,Simon Benita.Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs[J]. European Journal of Pharmaceutics and Biopharmaceutics . 2000 (1)
  • 7Shah NH,Carvajal MT,Patel CI,et al.Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. International Journal of Pharmaceutics . 1994
  • 8李良,刘国贞,梁月华.寒凉和温热药对大鼠脑、垂体和肾上腺内5-羟色胺及去甲肾上腺素神经元和纤维的影响[J].中国中药杂志,1999,24(6):360-362. 被引量:30

共引文献23

同被引文献38

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部